Physician profile
Akbar Ali
NPI 1578558219
$8,346.22
in general payments reported to CMS, 2019-2025
9 companies · $6,127 in 2025
The $6,127 reported for 2025 was more than what 92% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19.66 · 2021: $12.37 · 2022: $1,536 · 2023: $447 · 2024: $205 · 2025: $6,127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,000 · Travel and Lodging: $2,297 · Food and Beverage: $482.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,000.00 |
| Travel and Lodging | $2,296.75 |
| Food and Beverage | $481.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $6,515.43 | 2023-2025 | Da Vinci Surgical System |
| Olympus Corporation of The Americas | $1,619.23 | 2022-2023 | Olympus, 4k Cable 8.5m |
| Novartis Pharmaceuticals Corporation | $82.74 | 2023-2024 | |
| Olympus America INC. | $40.00 | 2025 | Olympus, Hd Camera Head |
| Lilly USA, LLC | $23.68 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $19.66 | 2019 | |
| Baxter Healthcare | $19.26 | 2024 | Perclot |
| Gilead Sciences, INC. | $13.85 | 2022 | |
| Jazz Pharmaceuticals INC. | $12.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Akbar Ali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.